Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1342 of 5804
-
New hope for drug-resistant GIST: combo therapy targets stubborn tumors
Disease control OngoingThis is an open label, single arm, phase 2 trial investigating bezuclastinib plus sunitinib in patients with GIST who have previously progressed on sunitinib.
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Ginseng vs. fatigue: major trial tests natural remedy for cancer patients
Symptom relief Recruiting nowThis phase III trial compares the effect of Wisconsin ginseng (panax quinquefolius) to placebo in patients with cancer that suffer from significant fatigue. Fatigue is among the most challenging symptoms to manage in patients with cancer, both on or off active treatment. This sym…
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New combo therapy aims to shrink deadly esophageal tumors
Disease control Recruiting nowThe goal of this clinical trial is to investigate the safety and efficacy of a new treatment approach for T4-stage esophageal cancer, which involves chemoradiotherapy after induction chemotherapy. The main questions it aims to answer are: * Does the new induction chemotherapy fo…
Phase: PHASE1, PHASE2 • Sponsor: National Cheng-Kung University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New heart procedure could replace pacemakers for fainting patients
Disease control Recruiting nowThe CNA-FWRD Registry is an international prospective observational multicenter registry of patients with symptomatic vasovagal syncope and bradyarrhythmias managed under routine care by medical therapy and radiofrequency catheter ablation of ganglionated plexi or permanent pacem…
Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 26, 2026 17:46 UTC
-
New hope for rare cancers: drug combo trial launches
Disease control Recruiting nowBackground: Rare tumors of the genitourinary (GU) tract can appear in the kidney, bladder, ureters, and penis. Rare tumors are difficult to study because there are not enough people to conduct large trials for new treatments. Two drugs-sacituzumab govitecan (SG) and atezolizumab…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New combo may boost stem cell harvest for lymphoma patients
Disease control Recruiting nowThis study utilizes a prospective, multicenter, randomized two-arm design to evaluate the efficacy and safety of the etoposide, cytarabine, and pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) combination therapy (EAP regimen) in mobilizing hematopo…
Phase: PHASE3 • Sponsor: The Affiliated People's Hospital of Ningbo University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug aims to keep night shift workers awake and safe
Symptom relief Recruiting nowSUSTAIN (Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder) is a Phase 3, multi-center, randomized, double-blind, placebo-controlled, parallel- group trial to assess the efficacy and safety of solriamfetol in adults with excessive sle…
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
AI tool spots pneumonia risk after brain surgery
Diagnosis CompletedPostoperative pneumonia (POP) is a common and serious complication after elective craniotomy for brain tumor resection. POP often develops within the first week after surgery and may lead to prolonged hospitalization, higher medical costs, and increased risk of severe illness. Be…
Sponsor: Ming Yang • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Gene therapy shot aims to fix gaucher disease in kids
Disease control OngoingThe purpose of this study was to evaluate the safety, tolerability, efficacy, immunogenicity, PD and PK characteristics of LY-M001 injection in children with GD1 aged 6 years ≤ age \< 18 years. This study mainly includes the main study stage and the long-term follow-up study stag…
Phase: EARLY_PHASE1 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New hope for myelofibrosis patients: tasquinimod trial launches
Disease control Recruiting nowTo learn if tasquinimod either alone or in combination with ruxolitinib can help to control PMF, post-PV MF, or post-ET MF.
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Breath and blood may reveal hidden cancer early
Diagnosis Recruiting nowThe goal of this minimally invasive interventional study is to learn if oncometabolic biomarkers, detected in the exhaled breath and blood can identify early-stage gastro-oesophageal cancer in patient at risk for gastro-oesophageal cancer. The main questions this study aims to a…
Phase: NA • Sponsor: KU Leuven • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
New shot aims to tame COPD Flare-Ups
Disease control OngoingA Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of Subcutaneous JKN24011 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Phase: PHASE2 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a single drug ease Crohn's gut blockages?
Disease control Recruiting nowThis study intends to select patients with confirmed moderate-to-severe Crohn's disease (CD) and obstructive symptoms of intestinal stenosis, who have clear evidence of lumen stenosis caused by the disease itself through radiography or endoscopy. After the informed consent of the…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
AI reads scans to pinpoint lung cancer type
Diagnosis Recruiting nowPET/CT imaging and clinical information (age, gender, smoking history, family history of cancer, history of present illness, and several tumor biomarkers, etc.) were used to establish a hierarchical multi-modal AI framework for pathological and genetic subtyping of lung cancer
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
New model helps surgeons choose best operation for rare liver cancer
Knowledge-focused CompletedThe Rboost causal model can identify patients who are most likely to benefit among HCC-BDTT patients. Adherence to the individualized recommendation improves survival. This data-driven tool offers vital support for precision surgical decision-making in this high-risk disease.
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Can a cancer drug sharpen the mind and hands in advanced MS?
Disease control Recruiting nowThe goal of this clinical trial is to know if rituximab can improve cognitive and hand functions in secondary progressive multiple sclerosis (SPMS) patients with high disability (EDSS 6.5 or more). The main questions it aims to answer are: Can rituximab improve cognitive and han…
Phase: PHASE2 • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Glowing poop test could spot rare infant liver disease
Diagnosis Recruiting nowBiliary atresia is a rare, progressive liver disease that only affects infants. It leads to complete obstruction and scarring of the bile duct. Current non-invasive diagnostic tests have limited sensitivity. Indocyanine Green (ICG) is a non-radioactive, fluorescent compound with…
Phase: PHASE1, PHASE2 • Sponsor: Boston Children's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
New program aims to help women with HIV and mental illness stay healthy
Disease control Recruiting nowThe study goal is to promote viral load suppression among women with serious mental illness (SMI) and HIV in Botswana, given that these women are especially vulnerable to psychiatric medication nonadherence and symptom exacerbation, which are made worse by stigma and threaten ant…
Phase: NA • Sponsor: New York University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can magnetic pulses help stroke survivors speak again?
Symptom relief Recruiting nowThe goal of this clinical trial is to determine if Transcranial Magnetic Stimulation (TMS) combined with modified Constraint Induced Language Therapy (mCILT) is an effective treatment for aphasia when delivered in the subacute stage after stroke. The main questions this study ai…
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a smartphone program ease Chemo's emotional toll?
Symptom relief CompletedBreast cancer is the most common malignant tumor among women. Side effects from initial chemotherapy include sleep disorders, anxiety, depression, and reduced quality of life. Mental health distress is also a major issue in cancer care. This study integrates mobile health informa…
Phase: NA • Sponsor: National Defense Medical Center, Taiwan • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC